Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Immuron Ltd ADR (NQ: IMRN )

2.251 -0.088 (-3.75%)
Streaming Delayed Price Updated: 2:32 PM EDT, May 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Immuron Ltd ADR

< Previous 1 2 3 4 5 Next >
Immuron Q3 FY23 Business Update Presentation
From Immuron Limited
Via GlobeNewswire
Q3 FY23 Business Update Webinar Notification
From Immuron Limited
Via GlobeNewswire
Immuron Q3 Sales reach 150% of 1H Sales
From Immuron Limited
Via GlobeNewswire
Immuron CEO, Steven Lydeamore to host an investor webinar
From Immuron Limited
Via GlobeNewswire
Immuron Announces Strategic Investment In UK-Based Gut Health Company
Via Benzinga
Immuron Pulls Plug On COVID-19 Treatment Hopeful, Citing Changing Landscape
Via Benzinga
Immuron US DoD Naval Medical Research Center responds to FDA Clinical Hold for New Campylobacter ETEC Therapeutic
From Immuron Limited
Via GlobeNewswire
US Department of Defense Uniformed Services University Clinical Evaluation of Travelan™ Achieves 150 Recruitment Milestone
From Immuron Limited
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Immuron Receives European Patent on Drug Composition to Treat Clostridioides difficile Associated Disease
From Immuron Limited
Via GlobeNewswire
Immuron's IND Application For Bacterial Infection Candidate Placed On Clinical Hold
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Dow Rises 150 Points; Mission Produce Shares Slide
U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining around 150 points on Friday. 
Via Benzinga
Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Dow Surges Over 100 Points; Crude Oil Rises Sharply
U.S. stocks traded mostly higher midway through trading, with the Dow Jones gaining over 100 points on Friday. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why DBV Technologies Shares Are Trading Higher By 38%; Here Are 26 Stocks Moving Premarket
Gainers Expion360 Inc. (NASDAQ: XPON) shares rose 152% to $2.47 in pre-market trading. Expion360 been selected as the exclusive supplier of high-energy lithium ion batteries for an overland trailer... 
Via Benzinga
Immuron Receives FDA Approval for Travelan IND Application
From Immuron Limited
Via GlobeNewswire
Why AMC Entertainment Shares Are Trading Lower By Around 13%? Here Are 59 Stocks Moving In Thursday's Mid-Day Session
Gainers Core Scientific, Inc. (NASDAQ: CORZ) shares jumped 188% to $0.1471. Core Scientific shares dipped 75% on Wednesday after the company filed for Chapter 11 bankruptcy. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Immuron Submits IND Application To FDA for Travelan
From Immuron Limited
Via GlobeNewswire
Immuron completes strategic investment in leading gut health biotech Ateria Health
From Immuron Limited
Via GlobeNewswire
Immuron CEO, Steven Lydeamore to present at AusBioInvest
From Immuron Limited
Via GlobeNewswire
Immuron strategic investment in leading gut health biotech Ateria Health
From Immuron Limited
Via GlobeNewswire
Why Nauticus Robotics Shares Are Trading Higher By 96%; Here Are 67 Biggest Movers From Yesterday
Gainers Chardan NexTech Acquisition 2 Corp. (NASDAQ: CNTQ) shares surged 102.6% to close at $21.54 on Wednesday. 
Via Benzinga
Why Sotera Health Shares Are Trading Lower By Around 13%, Here Are 38 Stocks Moving In Wednesday's Mid-Day Session
Gainers Pineapple Energy Inc. (NASDAQ: PEGY) shares jumped 104% to $2.9201. Shares of this low-float penny stock closed up about 80% on Tuesday. 
Via Benzinga
Immuron Executes Travelan Clinical Trial Agreement with US-based Pharmaron
From Immuron Limited
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
  
Via Benzinga
Daily Biotech Pulse: EU Approval For AbbVie's Ulcerative Colitis Treatment, Angion Biomedica Evaluates Alternatives, Clinical Hold For Immuron's Bacterial Infection Candidate
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.